TAUOPATHIES TREATMENT MARKET ANALYSIS

Tauopathies Treatment Market, by Disease (Frontoyemporal Degeneration (Pick’s Disease, CBD, and PSP), Alzheimer’s Disease, and Other Neurodegenerative Diseases), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Sales), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jul 2023
Code : CMI3995
Pages :160
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Tauopathies Treatment Market - Key Players

The major players operating in the global tauopathies treatment market include Avanir Pharmaceuticals, Inc., Otsuka Pharmaceutical Co., Ltd., AB Science, Cortice Biosciences, REGENXBIO Inc., Aquinnah Pharmaceuticals, Neurimmune, Oligomerix, Inc., Biogen, TauRx, Sellas, Catalent Inc., Selvita S.A, Bristol-Myers Squibb Company, Chronos Therapeutics Limited, and SK Biopharmaceuticals Co., Ltd.